It is an inhibitory receptor on NK and T cells that binds to HLA-E on target cells, suppressing NK cell activation and contributing to immune evasion in cancer.103 Tumor cells often exploit the NKG2A-HLA-E axis to escape immune detection. This evidence concerns the gene HLA-E and neoplasm.